Synopsis: Vijaypd Ceutical Limited (VIJAYPD) has secured a significant Memorandum of Understanding (MoU) with Ann Finechem LLP for the bulk supply of Active Pharmaceutical Ingredients (APIs) valued at over Rs. 30 crore. Following the announcement, the stock defied a broader market sell-off to hit a new 52-week high.
Vijaypd Ceutical Limited announced on April 30, 2026, that it has entered into a strategic Memorandum of Understanding (MoU) with Ann Finechem LLP. The agreement outlines a framework for the bulk purchase and sale of specific Active Pharmaceutical Ingredients (APIs), specifically Lumefantrine and Artemether.
Under the terms of the agreement, Ann Finechem LLP proposes to purchase these APIs in bulk quantities amounting to Rs. 30.2 crore over a period of one year. The MoU serves as a framework for issuing formal Purchase Orders, which will detail product specifications, quantities, and delivery schedules. This collaboration is intended to establish a consistent supply chain and leverage the technical expertise of both parties for market expansion and business development.
This MoU is strategically significant as Lumefantrine and Artemether are critical components of Artemisinin-based Combination Therapy (ACT). By securing this Rs. 30 crore supply framework, Vijaypd is positioning itself as a vital player in the anti-malarial supply chain, which has faced global disruptions due to the ongoing 2026 shipping blockades in the Middle East.
The stock market responded with strong optimism to the announcement, with Vijaypd Ceutical’s shares surging 4.90% to reach Rs. 109.15. This performance was particularly notable as it occurred during a sharp broader market decline, with the NIFTY 50 falling 1.52% (368.40 points).
During early trade, the stock hit a fresh 52-week high of Rs. 109.25, marking a significant recovery from its 52-week low of Rs. 35.00 set in October 2025. The company, which now commands a market capitalization of Rs. 211.11 crore, has demonstrated exceptional momentum with a one-month absolute return of 67.41% and a year-to-date gain of 158.04%.
Company Overview
Vijaypd Ceutical Limited is an NSE-listed pharmaceutical company primarily engaged in the Pharmacy Retail and API sourcing sector. Headquartered in Mumbai, the company was listed on the NIFTY SME EMERGE index on October 7, 2025. The company focuses on building a robust supply chain for critical pharmaceutical ingredients and expanding its footprint in the domestic API trading market.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Vijaypd Ceutical Bags ₹30 Crore API Order; Shares Hit 52-Week High appeared first on Trade Brains.